» Articles » PMID: 35402843

Ultrastructural Alterations of Megakaryocytes in Thrombocytopenia: A Review of 43 Cases

Overview
Journal Blood Sci
Date 2022 Apr 11
PMID 35402843
Authors
Affiliations
Soon will be listed here.
Abstract

Thrombocytopenia is a frequent occurrence in a variety of hematopoietic diseases; however, the details of the mechanism leading to low platelet count remain elusive. Megakaryocytes are a series of progenitor cells responsible for the production of platelets. Alterations in megakaryocytes in the bone marrow are a causative factor resulting in thrombocytopenia in varied diseases. Based on ultrastructural analysis of incidentally encountered megakaryocytes in 43 patients with blood diseases marked by low platelet counts, electron micrographs demonstrated that aberrant megakaryocytes predominated in idiopathic thrombocytopenic purpura, aplastic anemia, and myelodysplastic syndrome; autophagy, apoptosis, and cellular damage in megakaryocytes were a prominent feature in aplastic anemia. On the other hand, poorly differentiated megakaryocytes predominated in acute megakaryoblastic leukemia (AMKL) although damaged megakaryocytes were seen in non-AMKL acute leukemia. This paper documents the ultrastructural alterations of megakaryocytes associated with thrombocytopenia and reveals distinctive features for particular blood diseases. A comment is made on future avenues of research emphasizing membrane fusion proteins.

Citing Articles

Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia.

Liu Y, Zuo X, Chen P, Hu X, Sheng Z, Liu A Signal Transduct Target Ther. 2022; 7(1):347.

PMID: 36202780 PMC: 9537316. DOI: 10.1038/s41392-022-01167-9.


Erratum: Ultrastructural alterations of megakaryocytes in thrombocytopenia: A review of 43 cases.

Blood Sci. 2022; 4(1):47.

PMID: 35189629 PMC: 8845529. DOI: 10.1097/BS9.0000000000000096.

References
1.
Elzaeem D, Sharkawi E, Zaki E, Ghobrial A, El-Fatah A, El-Hamed W . Comparative study of IgG binding to megakaryocytes in immune and myelodysplastic thrombocytopenic patients. Ann Hematol. 2021; 100(7):1701-1709. DOI: 10.1007/s00277-021-04556-2. View

2.
Singh A, Verma A, Nityanand S, Chaudhary R, Elhence P . Circulating thrombopoietin levels in normal healthy blood donors and in aplastic anemia patients in relation to disease severity. Asian J Transfus Sci. 2015; 9(1):70-3. PMC: 4339937. DOI: 10.4103/0973-6247.150956. View

3.
Mahabir V, Ross C, Popovic S, Sur M, Bourgeois J, Lim W . A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia. Eur J Haematol. 2012; 90(2):121-6. PMC: 3938453. DOI: 10.1111/ejh.12041. View

4.
Vainchenker W, Raslova H . Megakaryocyte polyploidization: role in platelet production. Platelets. 2019; 31(6):707-716. DOI: 10.1080/09537104.2019.1667497. View

5.
Ru Y, Zhao S, Dong S, Liang H, Wang Y . Systematic alteration of apoptosis: a review with ultrastructural observations on leukemia cells in vivo. Ultrastruct Pathol. 2017; 42(1):1-9. DOI: 10.1080/01913123.2017.1373176. View